The potentiation of radiation response on murine tumor by fludarabine phosphate
- 1 April 1986
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 31 (1), 69-76
- https://doi.org/10.1016/0304-3835(86)90168-0
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Phase I clinical trial of fludarabine phosphate (F-ara-AMP)Cancer Chemotherapy and Pharmacology, 1985
- Inhibition of the recovery from potentially lethal damage by lonidamineBritish Journal of Cancer, 1984
- Radiosensitization of Meth-A Fibrosarcoma in Mice by LonidamineOncology, 1984
- The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair processBritish Journal of Cancer, 1982
- Purine Nucleoside Analogues Inhibit the Repair of Radiation-induced Potentially Lethal Damage in Mammalian Cells in CultureInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1982
- Effects of β-Arabinofuranosyladenine on the Growth and Repair of Potentially Lethal Damage in Ehrlich Ascites Tumor CellsRadiation Research, 1980
- Biologic activity of 9-β-d-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-β-d-arabinofuranosyladenineBiochemical Pharmacology, 1977
- Inhibition of Unscheduled DNA Synthesis and Repair of Potentially Lethal X-ray Damage by 2-deoxy-D-glucose in YeastInternational Journal of Radiation Biology, 1977
- The Antiviral Activity of 9-β-D-Arabinofuranosyladenine (ARA-A)Chemotherapy, 1968